Printer Friendly
The Free Library
19,607,059 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

DECODE SELECTS MILLIPORE MULTISCREEN PURIFICATION PLATFORM.


deCODE genetics deCODE genetics, Inc. (Íslensk erfðagreining in Icelandic) NASDAQ: DCGN is a biopharmaceutical company based in Reykjavík, Iceland. The company was founded in 1996 to identify human genes associated with common diseases using population studies, and apply the  (Nasdaq/Nasdaq Europe:DCGN) and Millipore Corporation For other uses, see Millipore.
Millipore Corporation (NYSE: MIL) founded in 1954, listed among the S&P 500 since the early 1990s, is an international biosciences company, known widely for its micrometer pore-size filters and tests.
 (NYSE/MIL) have announced that deCODE has selected Millipore's MultiScreen(TM)384 platform to purify Purify - A debugging tool from Pure Software.  their samples prior to DNA sequencing DNA sequencing

The determination of the sequence of nucleotides in a sample of DNA.
.

Based in Reykjavik, deCODE utilizes Iceland's unique genealogical ge·ne·al·o·gy  
n. pl. ge·ne·al·o·gies
1. A record or table of the descent of a person, family, or group from an ancestor or ancestors; a family tree.

2. Direct descent from an ancestor; lineage or pedigree.
 resources to conduct population-wide DNA DNA: see nucleic acid.
DNA
 or deoxyribonucleic acid

One of two types of nucleic acid (the other is RNA); a complex organic compound found in all living cells and many viruses. It is the chemical substance of genes.
 linkage analyses to identify the inherited causes of common diseases. "We operate one of the highest-throughput disease-gene research operations in the world," said Dr. Jeff Gulcher, deCODE's vice president for Research and Development, "and we are able to focus our sequencing on small regions of the genome specifically linked to disease. But with more than 40 disease programs underway, we need our sequencing to be highly efficient and to yield the most accurate data possible. The Millipore384-well platform fits our high-throughput model and gives us very clean DNA."

Millipore's MultiScreen384 platform is a new, high-throughput membrane-based system for biomolecular separations. Based upon a size exclusion technology, the MultiScreen384 platform is automation-compatible, making it an ideal sample preparation method for the high throughput demands of the world's leading genomics centers.

About deCODE genetics

deCODE genetics (www.decode.com), based in Reykjavik, Iceland, is conducting research into the inherited causes of common diseases. Through its population-based approach and three main business units providing disease-gene and drug target identification, database services and informatics Same as information technology and information systems. The term is more widely used in Europe.  tools, deCODE is turning raw genomics data into products and services for the healthcare industry.

About Millipore

Millipore is a multinational, high technology company that applies its purification technology to critical research and manufacturing applications in the biosciences and microelectronics industries. In biosciences, Millipore provides technologies, tools and services for the development and production of new therapeutic drugs. For more information visit, www.millipore.com. In microelectronics, Millipore provides products, components and services for the production of semiconductor devices. For more information visit, www.mykrolis.com.

For more information, call (781)533-2225 or visit http://www.Millipore.com.
COPYRIGHT 2001 Worldwide Videotex
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2001, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Worldwide Biotech
Date:Jul 1, 2001
Words:311
Previous Article:EXPANDED HUMAN TESTING OF NASAL FLU VACCINE BEGINS.
Next Article:BIOCORAL RECEIVES FRENCH PATENT APPROVAL.
Topics:



Related Articles
Millipore Announces Plans to Form Two Independent Companies Focused on Biosciences and Microelectronics.
Millipore Ensures Maximum IT Infrastructure Uptime Using InteQ InfraWatch.
Millipore and Proteome Systems Announce Plans for Proteomics Kit Development.
Millipore and MWG-Biotech To Co-Market Integrated Genomics Solutions.
deCODE genetics Supports High-Throughput Disease-Gene Research with Millipore's MultiScreen384 Purification Platform.
APPLIED BIOSYSTEMS/MILLIPORE FUND UNIV. OF TOKYO PROTEOMICS.
Millipore and Proteome Systems Launch In-Gel Digest Kits for Protein Sample Preparation.
PerkinElmer Life Sciences and Millipore to Co-Market Total Automated Sample-Prep Solutions.
PerkinElmer Life Sciences and Millipore to Co-Market Total Automated Sample-Prep Solutions.
Voith Paper gets order from Nordland.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles